
Merck plans to move manufacturing of its biggest drug, Keytruda, to a new U.S. factory and lab in Delaware
Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market. Keytruda is currently made in Ireland and by contract …